Illumina

Illumina, Inc. is an American company that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. Using its technologies, the Company provides a line of products and services that serve the sequencing, genotyping and gene expression markets. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies.

Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1998
Size (employees)
5,500 (est)
Illumina was founded in 1998 and is headquartered in San Diego, US

Illumina Office Locations

Illumina has offices in San Diego, Madison, San Francisco, Santa Clara and in 11 other locations
San Diego, US (HQ)
5200 Illumina Way
Victoria, CA
2302 4464 Markham St
Singapore, SG
11 Biopolis Way, #09-05 Helios
Fulbourn, GB
CPC4, Capital Park
Little Chesterford, GB
Chesterford Research Park Little Chesterford Nr Saffron Walden
Eindhoven, NL
15 Freddy van Riemsdijkweg
Show all (15)

Illumina Financials and Metrics

Illumina Financials

Illumina's revenue was reported to be $598 m in Q1, 2018
USD

Revenue (Q1, 2018)

598 m

Gross profit (Q1, 2018)

368 m

Gross profit margin (Q1, 2018), %

62%

Net income (Q1, 2018)

348 m

EBIT (Q1, 2018)

52 m

Market capitalization (20-Oct-2017)

30.9 b

Cash (02-Apr-2017)

981 m
Illumina's current market capitalization is $30.9 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

1.4 b1.9 b2.2 b2.4 b2.4 b

Revenue growth, %

31%19%8%

Cost of goods sold

670.5 m731.9 m731.9 m

Gross profit

1.5 b1.7 b1.7 b
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

447.6 m480.6 m538.6 m539.4 m550.3 m571.8 m600.1 m607.1 m598 m

Cost of goods sold

147 m146.7 m163.5 m163 m162.7 m174.7 m176.3 m181 m230 m

Gross profit

300.5 m333.9 m375 m376.4 m387.5 m397.1 m423.8 m426.2 m368 m

Gross profit Margin, %

67%69%70%70%70%69%71%70%62%
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

711.6 m636.2 m768.8 m734.5 m734.5 m

Accounts Receivable

238.9 m289.5 m385.5 m381.3 m381.3 m

Inventories

22.8 m29.8 m54.3 m77.9 m300.2 m

Current Assets

1.6 b1.9 b2.1 b2.3 b2.3 b
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

675.2 m829.9 m533.5 m591.1 m551.5 m754.9 m951.7 m794.7 m981 m

Accounts Receivable

258.7 m276.7 m350 m368.6 m413.5 m402.5 m372.5 m381.6 m368 m

Inventories

177.5 m199.3 m205.2 m223.6 m233.8 m287.9 m311.4 m312.2 m299 m

Current Assets

1.6 b1.9 b2.1 b2.2 b2.2 b2.1 b2.1 b2.3 b2.5 b
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

125.3 m353.4 m457.4 m428.1 m428.1 m

Depreciation and Amortization

50.8 m61.9 m72.7 m90 m90 m

Accounts Receivable

(16 m)(50 m)(96 m)3.2 m3.2 m

Inventories

1.8 m6.6 m(11 m)(1.2 m)(29.7 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Net Income

46.6 m93.5 m136.7 m102.2 m115.6 m87.2 m116.4 m116.9 m348 m

Accounts Receivable

258.7 m276.7 m350 m368.6 m413.5 m402.5 m372.5 m381.6 m368 m

Inventories

177.5 m199.3 m205.2 m223.6 m233.8 m287.9 m311.4 m312.2 m299 m

Accounts Payable

91.5 m96.1 m106.7 m107.9 m123.4 m154.7 m250.7 m134.1 m142 m
Y, 2017

Financial Leverage

1.8 x
Show all financial metrics

Illumina Market Value History

Illumina Median Salaries

Source: 236 public H-1B filings from Illumina

Traffic Overview of Illumina

Illumina Online and Social Media Presence

Illumina News and Updates

Illumina Ventures collects $230 mln for maiden fund

San Francisco-based Illumina Ventures, an early-stage venture firm, has raised $230 million for its debut fund. Illumina invests in early-stage companies focused on genomics and precision medicine.

Telegraph Partners and Illumina form Verogen

Telegraph Partners and Illumina Inc have launched San Diego-based Verogen Inc, which will accelerate development of Illumina’s forensic genomics technologies. No financial terms were disclosed. Kirk Malloy will serve as CEO.

Illumina Company Life and Culture

You may also be interested in